Exercise may improve outcomes for patients with hematologic cancers
the ONA take:
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue and additional outcomes in patients with hematologic cancer following treatment, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because patients with hematologic malignancies exhibit significant physical deconditioning and psychological distress after treatment, researchers sought to evaluate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue and related outcomes in these patients following treatment.
Researchers enrolled 37 patients and randomly assigned them 1:1 to participate in the 12-week exercise rehabilitation or usual care.
The rehabilitation consisted of tailored exercise programs comprising aerobic and resistance exercises performed three times weekly for 12 weeks in local gyms and clinics. Those in the usual care group were offered a delayed, tailored 12-week exercise program after the initial study period.
The study demonstrated that the 12-week exercise rehabilitation program resulted in significant improvement in cancer-related fatigue, cardiovascular fitness, quality of life, muscle strength, and body composition. The delayed 12-week exercise program also showed similar significant improvements in patient outcomes.
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|